Knowledge translation research offers new perspective on treating stimulant use disorder
How diverse patient perspectives can be used to inform future clinical research and practice
Read MoreHow diverse patient perspectives can be used to inform future clinical research and practice
Read MoreDrs. Eugenia Oviedo-Joekes and Anne Gadermann are among the 156 new and renewed Canada Research Chairs
Read MoreAs we enter into another exciting year of improving health outcomes for B.C. and beyond, we’re reflecting on some of the CHÉOS research from the past year
Read MoreCOVID-19 is one of the two public health emergencies currently facing British Columbia, writes Dr. Eugenia Oviedo-Joekes
Read MorePatient Voices is dedicated to amplifying the voices of research participants. Spike is a participant in the Opiate Assisted Therapy program provided by Providence Health Care’s Crosstown Clinic.
Read MoreCHÉOS Trainee Kirsten Marchand recently explored the experiences of clients receiving injectable opioid agonist treatment.
Read MoreAs we enter into another exciting year of improving health outcomes for BC and beyond, we're reflecting on some of the CHÉOS research from the past year.
Read MoreCHÉOS Scientist Dr. Eugenia Oviedo-Joekes is a co-author on the first-ever clinical guidelines for use of injectable opioid agonist treatment for opioid use disorder.
Read MoreRead about the Scientists and research that appeared in the media this summer.
Read MoreDr. Eugenia Oviedo-Joekes is mentoring a team exploring dexamphetamine for treatment of patients receiving iOAT.
Read More